The Hollow Villain: How Stigma Distracts Us from Action 

In the world of addiction, “stigma” often gets cast as the ultimate villain—the big bad wolf of public health narratives. It’s the term we throw around when we talk about shame, isolation, and the barriers people face when seeking treatment. The problem with the term stigma is that it's broad and elusive, seeming to apply … Continue reading The Hollow Villain: How Stigma Distracts Us from Action 

Another buprenorphine study with poor outcomes for young patients

  A recent study looks at buprenorphine retention and frames young adult retention as a problem. Emerging adults (18-25 years old) are often poorly retained in substance use disorder treatment. Office-based buprenorphine often enhances treatment retention among people with opioid dependence. In this study, we examined the records of a collaborative care buprenorphine treatment program … Continue reading Another buprenorphine study with poor outcomes for young patients